Navigation Links
CpGenome™ Universal DNA Modification Kit from Upstate

ProductsCpGenome™ Universal DNA Modification Kit from Upstate
Company Upstate
Item CpGenome™ Universal DNA Modification Kit
Price $290.00
Description 
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. CpGenome™ Fast DNA Modification Kit from CHEMICON
2. Horizontal Laminar Flow Work Station from Terra Universal, Inc.
3. MetaVue from Universal Imaging Corporation (a subsidiary of Molecular Devices)
4. GenePix Pro from Universal Imaging Corporation (a subsidiary of Molecular Devices)
5. MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
6. Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
7. Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
8. Vertical Laminar Flow Work Station from Terra Universal, Inc.
9. Down Draft Work Station from Terra Universal, Inc.
10. Heated Processing Chamber from Terra Universal, Inc.
11. Pharmaceutical Compounding Chamber from Terra Universal, Inc.
... P450 (CYP450) metabolite postulated to play an ... vasculature. In rat cerebral microvessels, 20-HETE is ... 20-HETE is excreted mainly as the glucuronide ... pg/ml in human urine) is about 10-fold ...
... Most sensitive silver stain. ... stop baths or reversers needed. ... and polysaccharides. Linear protein-to-stain ... stain multiple gels per tray. ...
... are designed to rapidly and reliably amplify ... APA Technology. APAgene provides hassle-free, ready-to use ... necessary ingredients are provided in each kit. ... for gap filling, localized cloning of genomic ...
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
Biology Products:
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... break down cellulose (chunks of wood pulp), a process ... chemicals like chlorine. Nature performs the same task using ... far less energy. The catch is that the enzymes ... hold up to the high temperatures of the manufacturing ...
... Technology (NIST) and in Lithuania have used a NIST-developed ... detect and measure a protein associated with a serious ... The work illustrates how the artificial membrane could be ... bacteria Gardnerella vaginalis , BV is a very ...
... This news release is available in German . ... the death of thousands of neurons in the brain. Nerve growth ... of the neurons; however, clinical tests with GDNF have not yielded ... Neurobiology in Martinsried and their colleagues have now succeeded in demonstrating ...
Cached Biology News:Expanding the range of nature's catalysts for industrial applications 2Expanding the range of nature's catalysts for industrial applications 3NIST cell membrane model studied as future diagnostic tool 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 3
(Date:6/1/2015)... , May 29, 2015 ... the addition of the "2015 Assessments ... Major Suppliers and Recent Market Entrants" ... new 90-page report from VPGMarketResearch.com provides insightful ... recent market entrants. The report ...
(Date:6/1/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration partner, presented ... trial of HMP,s c-Met inhibitor savolitinib (AZD6094) combined ... lung cancer ("NSCLC"). AZD9291 is AstraZeneca,s ... (EGFR). Preliminary data on the activity of AZD9291 ...
(Date:5/31/2015)... , June 1, 2015 ... rare diseases, has selected Veeva Commercial Cloud to ... and medical. A complete solution, Veeva Commercial ... and compliant content to provide a comprehensive view ... execution.      (Logo: http://photos.prnewswire.com/prnh/20120425/527164) , ...
(Date:5/31/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today announced interim findings from ... investigational new drug PEGPH20 for the potential treatment ... The encouraging interim data was presented today at ... in an oral presentation by Principal Investigator ...
Breaking Biology Technology:Assessments of Leading Microbiology Market Players 2015 - Profiles of Major Suppliers and Recent Market Entrants 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 2Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 2Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 4Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 5